Drug Development Strategy
Regulatory Services and Support
CMC Services
Nonclinical Services
Clinical & PK Services
The Camargo Story
The Camargo Way
Camargo Blog
What is 505(b)(2)?
Download and learn from our latest pharmaceutical development webinars.
Achieving Long-Term Success for Your Development Program — Mike Dial and Tim Sullivan
Achieving Long-Term Success for Your Development Program Advice from Industry Experts for Early-stage Sponsors, Part...
Achieving Long-Term Success for Your Development Program — Mark McCamish
505(b)(2) Planning: Regulatory and Study Conduct Best Practices
505(b)(2) Planning: Regulatory and Study Conduct Best Practices Date: June 26, 2020 Presented by: Kristi...
The Value of Real World data in Orphan and 505(b)(2) Drug Development
DownloadDate: October 9th, 2019 Presented by: Ken Phelps, president and co-founder, Camargo In orphan drug...
The 505(b)(2) Pathway: Getting to the Clinic Faster
Download Date: July 17th, 2019 Presented by: Ken Phelps, president and co-founder, Camargo You've identified your product...
The 505(b)(2) Pathway: What is it? And What Does it Mean for Pre-IND and NDA Submission?
DownloadDate: May 29th, 2019 Presented by: Ken Phelps, president and co-founder, Camargo To bring a new drug...
The Early Stage Therapeutics Investors Panel
View Date: September 26th, 2017 Location: RESI in Boston, Massachusetts Presented by: Ken Phelps, president and co-founder, Camargo
Early 505(b)(2) Strategy for Long-term Success
View Date: June 19th, 2017 Location: RESI in San Diego, California Presented by: Ken Phelps, president and co-founder,...
505(b)(2), Why Now? With Hands On the Project Case Study
Download Date: January 2nd, 2017 Location: DCAT Week 2017 Presented by: Ken Phelps, president and co-founder, Camargo, with...
How to Use 505(b)(2) to Achieve Commercial Success
Date: November 30th, 2016 Location: FierceLive! Webinars Presented by: Ken Phelps, president and co-founder, Camargo
Connect with Camargo today.
"I recently commented to our Camargo lead that all virtual biopharma companies should engage Camargo as a strategic partner. It is not only the depth of regulatory experience—meeting with the FDA five to six times a month—and the breadth of functional expertise, but also their responsiveness. Camargo is a key strategic partner that will help us succeed and bring our life-saving products to market."
Biotech President and CEO
Opioid Abuse-deterrent Technology
Camargo Pharmaceutical Services specializes in complex drug development programs where no playbook exists, with integrated strategy, regulatory, and development solutions that enable sponsors to reach milestones with speed and capital efficiency.
One East 4th Street
Durham Office
800 Taylor Street
Montreal Office
507 Place d'Armes
Montreal, QC H2Y 2W8, Canada
SUBSCRIBE FOR OUR LATEST INSIGHTS
9825 Kenwood Road
Durham NC, 27701
Terms of Use Privacy Policy © 2020 Camargo Pharmaceutical Services | Sitemap